Our data provide a biological explanation for this observation, showing that the vasculature of brain metastases is stable, and (extrapolating from observations in rectal cancer) (Willett et al, 2004) is unlikely to regress following anti-VEGF therapy, minimising the risk of associated haemorrhage. The gene discussed is VEGFA; the disease is rectal cancer.